Navigation Links
Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer
Date:10/27/2009

o be working with Astellas to develop MDV3100 for a broad spectrum of prostate cancer disease states," said David Hung, M.D., president and chief executive officer of Medivation. "Astellas is an ideal partner for MDV3100 given its global reach, leading commercial presence in the urology space, and strategic focus on oncology. Astellas is the second major collaboration we have completed in the past year, and we are confident we have the right partners in place for each of our late-stage programs--Astellas for MDV3100 and Pfizer, Inc for dimebon (latrepirdine*)."

According to the American Cancer Society, prostate cancer is the most common non-skin cancer among men in the United States. More than 2 million American men have prostate cancer, and it is the second leading cause of cancer death among men after lung cancer. In 2009, an estimated 192,000 new cases are expected to be diagnosed, and approximately 27,000 men are expected to die from the disease.

MDV3100, a new generation of oral anti-androgen, which shows different pharmacological profiles from current anti-androgens, has been shown in preclinical studies to provide more complete suppression of the androgen receptor pathway than bicalutamide, the most commonly used anti-androgen. MDV3100 slows growth and induces cell death in bicalutamide-resistant cancers via three complementary actions - MDV3100 blocks testosterone binding to the androgen receptor, impedes movement of the androgen receptor to the nucleus of prostate cancer cells (nuclear translocation), and inhibits binding to DNA. Preclinical data published in Science earlier this year demonstrated that MDV3100 is superior to bicalutamide in each of these three actions.

The agreement is not subject to approval under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and becomes effective immediately. Medivation's legal and financial advisers on the transaction were Cooley Godward Kronish LLP and Aquilo Partne
'/>"/>

SOURCE Medivation, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer
2. Medivation Announces Positive New Efficacy Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients
3. Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimers Disease
4. Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients
5. Medivation Presents Positive New Data on Dimebons Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimers Disease
6. Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimers Disease
7. Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntingtons Disease
8. Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntingtons Disease
9. Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimers Disease
10. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting
11. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... THOUSAND OAKS, Calif. , May 22, ... today announced the Company has commenced termination ... commercialization of brodalumab with AstraZeneca (LON:AZN, STO:AZN ... investigational IL-17 inhibitor, is in development for ... and axial spondyloarthritis.  The decision was based ...
(Date:5/22/2015)... OTTAWA , May 22, 2015 /CNW/ - More than ... prescribed to treat morning sickness in expectant mothers. Tragically, Thalidomide ... children and families. Support has been provided ... the Government of Canada in 1991 ... the absence of a legal obligation to provide support, we ...
(Date:5/22/2015)... 22, 2015  BioLife Solutions, Inc. (NASDAQ: BLFS ), ... hypothermic storage and cryopreservation freeze media ... tissues ("BioLife" or the "Company"), announced that the Company is ... The Company is scheduled to present at the ... at the Grand Hyatt Hotel in New York ...
Breaking Medicine Technology:Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5Statement from Minister Ambrose on Thalidomide 2Statement from Minister Ambrose on Thalidomide 3BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2
... Porous Technologies, a developer and manufacturer of custom fluid-handling ... introduce a new range of hydrophilic, polyurethane foams for ... trade fair in Dusseldorf, Germany from 16 to 18 ... New innovations to be featured at the ...
... Texas, Nov. 2, 2011 Novation commends the White ... facing America,s hospitals through its October 31st Executive Order. ... support of the bipartisan legislation – (S. 296 and ... to establish a framework by which the quality and ...
Cached Medicine Technology:Filtrona Porous Technologies to Introduce New Hydrophilic Foam Products for Advanced Wound Care at the MEDICA / COMPAMED Trade Fair 2
(Date:5/24/2015)... (PRWEB) May 24, 2015 Indiana Fiber ... provider announces Midwest Telecom of America, Inc. (MTA) has ... According to Cory Childs, IFN Enterprise Sales Manager, fiber ... providers. “IFN’s fiber transport provides MTA with the ... to their Tier 1 Internet and voice carriers located ...
(Date:5/24/2015)... Santa Rosa, CA (PRWEB) May 24, 2015 ... gives a clear indicator that the single best option ... This study reveals that fitness level was the single ... researchers accounted for variables such as diabetes and family ... the significance of maintaining lifelong heart and lung fitness. ...
(Date:5/23/2015)... 2015 Dr. David Benvenuti, an experienced plastic ... a new article to his website that takes ... Benvenuti explained in the fascinating blog, he has recently ... earlobes. , Known as “gauging,” the technique involves placing larger ... Benvenuti said will eventually stretch the holes out to incredible ...
(Date:5/23/2015)... On May 16, the team at Farrell’s ... 5k mud obstacle run that raised funds for multiple sclerosis. ... and the reason we participated was to support people living ... Farrell’s eXtreme Bodyshaping. “One-hundred percent of the funds raised go ... was not only attended by eXtreme Bodyshaping staff, but members ...
(Date:5/23/2015)... WI (PRWEB) May 23, 2015 ... Acceleration at the Sports Medicine and Rehabilitation Center, 557 ... clinic program, Mondays, June 1-July 20, 5:30-6:30 pm. , ... USAT coach, and Laurie Finke, RN, BSN, who will ... exercises, education on nutrition, running mechanics and show selection ...
Breaking Medicine News(10 mins):Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 3Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2
... then you need to talk about your feelings with someone, ... will help you feel better. ,The study found ... or even putting your feelings down on paper, produces a ... ,Psychologists at UCLA, led by Dr Matthew D. Lieberman, ...
... Heritage sites, including Mount Everest, could be at risk from ... groups . ,Urging the United Nations to act ... Justice Programme have petitioned the global body to list the ... signed the UN World Heritage Convention have a legal duty ...
... Former Spice girl Victoria Beckham is reportedly planning to undergo ... the 33-year-old has suffered a lot because of her painful ... operation. ,'Victoria has had enough of having bad ... rather unpleasant bunions removed," the Daily Mail quoted the source, ...
... insulation, anyone? Eben Bayer of Vermont and his colleague ... ,The two have together created and already patented ... flour, oyster mushroom spores and perlite, a mineral blend ... soon be part of the growing market for eco-friendly ...
... For hundreds of years, Tibetan monks and other religious people ... This week, a new study shows exactly how one ... a scanner that reveals which parts of the brain are ... increased activity in the brain regions used for paying attention ...
... effective than one-on-one phone counseling. As Americans struggle to ... and motivation can play a crucial role in getting ... found feedback delivered via mail was equally as effective ... more effective long-term than feedback delivered via phone counseling. ...
Cached Medicine News:Health News:Talking About Your Feelings Really Does Help 2Health News:Everest, Five Other World Heritage Sites Face Climate Change Risk 2Health News:US Whizkids Create Eco-friendly Building Material from Mushroom 2Health News:US Whizkids Create Eco-friendly Building Material from Mushroom 3Health News:Meditation Increases Attention - A Brain Scan Report 2Health News:Meditation Increases Attention - A Brain Scan Report 3Health News:Meditation Increases Attention - A Brain Scan Report 4Health News:Physical Activity can Be Increased by a Motivating Mail 2Health News:Physical Activity can Be Increased by a Motivating Mail 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: